| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Maloberti Renaud Bertrand serves as a Chief Commercial Officer at NDRA. Across recent SEC filings that breaks down to 0 buys and 7 sells. Those positions are worth an estimated $2K at current prices.
The biggest single holding is NDRA (~$2K) as Chief Commercial Officer. The recent filings there lean toward selling, a net 85,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 13, 2021 | NDRA Endra Life Sciences Inc. | Chief Commercial Officer | Sell | 20,000 | $1.08 | $21,684.80 | -92.7% | |
| Jan 8, 2021 | NDRA Endra Life Sciences Inc. | Chief Commercial Officer | Sell | 8,731 | $0.94 | $8,207.14 | -28.8% | |
| Jan 6, 2021 | NDRA Endra Life Sciences Inc. | Chief Commercial Officer | Sell | 11,269 | $0.94 | $10,592.86 | -27.1% | |
| Dec 17, 2020 | NDRA Endra Life Sciences Inc. | Chief Commercial Officer | Sell | 25,000 | $0.73 | $18,250.00 | -37.5% | |
| Nov 13, 2020 | NDRA Endra Life Sciences Inc. | Chief Commercial Officer | Sell | 10,000 | $0.81 | $8,100.00 | -13.1% | |
| Oct 1, 2020 | NDRA Endra Life Sciences Inc. | Chief Commercial Officer | Sell | 10,000 | $0.72 | $7,200.00 | -11.6% |